Trifluoperazine

ADVERTISEMENT

Identification

Molecular formula
C21H24F3N3S
CAS Number
117-89-5
IUPAC Name
10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine
Molecular Weight
480.50g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.4859g/cm3
Synonyms
trifluoperazine
Interesting facts

Interesting Facts About 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine

10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine is a fascinating compound found in the realm of medicinal chemistry. This compound is an example of the phenothiazine class, which has been extensively studied due to its interesting therapeutic properties.

Key Highlights:

  • Pharmacological Relevance: Compounds in the phenothiazine family are renowned for their antipsychotic properties. They have been utilized in the treatment of schizophrenia and various other mental health disorders.
  • Structural Features: This compound showcases a unique molecular structure characterized by a trifluoromethyl group. This functional group enhances its lipophilicity, making it more effective in crossing the blood-brain barrier.
  • Piperazine Derivatives: The presence of the 4-methylpiperazin-1-yl group adds to the molecular diversity and biological activity, illustrating the importance of structural modifications in drug development.
  • Fluorine in Therapeutics: The inclusion of fluorine atoms is becoming increasingly common in pharmaceuticals due to their influence on metabolism and biological activity.
  • Continued Research: Ongoing studies aim to explore the full potential of this compound and its derivatives, including their role in treating resistant forms of psychiatric disorders.

In summary, 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine not only highlights the ever-evolving field of medicinal chemistry but also emphasizes the importance of chemical innovation in addressing complex health conditions. As we advance our understanding of such compounds, the prospects for new therapies become increasingly promising.

ADVERTISEMENT